Controlled Hypothermic Storage and Time‐Shifting in Lung Transplantation: A Single‐Center Study
Clinical Transplantation · 2026-11 · 40 (11)
DOI: 10.1111/ctr.70684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, online erschienen am 09.11.2026. Verfasst von Andrew Keogan und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Creighton University, Phoenix, Arizona, USA. Hauptthemen laut MEDLINE: Lung Transplantation, Organ Preservation, Tissue Donors. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Purpose
This study compared lung transplant outcomes between cases using controlled hypothermic storage (CHS) donor lung transport with ischemic times > 6 h and those using cold static storage (CSS) transport with ischemic times < 6 h.
Methods
We retrospectively reviewed lung transplantations performed at our center from September 15, 2014 to March 29, 2025, excluding ex vivo lung perfusion, single‐lung, redo, and multi‐organ cases. Perioperative outcomes were assessed using univariate, multivariable, survival, and propensity‐matched analyses.
Results
Among 770 recipients, 87 (11.3%) and 683 (88.7%) received lungs preserved using CHS and CSS, respectively. In the CHS group, ischemic times were significantly longer (median, 11.0 vs. 4.3 h, p < 0.001), and transport distances were greater (median, 750 vs. 219 nautical miles, p < 0.001). CHS was associated with higher rates of daytime transplantation (79% vs. 51%, p < 0.001) and delayed chest closure (22% vs. 13%, p = 0.023). Primary graft dysfunction grade 3 (PGD3) at 72 h was lower in the CHS group (13% vs. 26%, p = 0.019), and CHS was independently associated with a lower risk of PGD3 on multivariable analysis (aOR 0.38, 95% CI 0.17–0.83, p = 0.016). In a propensity‐matched analysis, PGD3 at 72 h was lower in the CHS group, but the difference did not reach statistical significance (12% vs. 26%, p = 0.059). Kaplan–Meier analysis demonstrated similar survival between groups ( p = 0.53).
Conclusion
CHS enables the safe extension of ischemic time beyond conventional limits, facilitating broader geographic access and a shift toward increased daytime transplantation. Short‐term outcomes were comparable to those of CSS, with a lower incidence of PDG3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Creighton University, Phoenix, Arizona, USA.
- Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.
Zitieren
APA
Keogan, A., Lin, T., Shacker, M., Chang, L., Wang, L., Walia, R., Bremner, R. M., Huang, J., Zwintscher, N., Smith, M. A., & Schaheen, L. W. (2026). Controlled Hypothermic Storage and Time‐Shifting in Lung Transplantation: A Single‐Center Study. Clinical Transplantation, 40(11). https://doi.org/10.1111/ctr.70684
Vancouver
Keogan A, Lin T, Shacker M, Chang L, Wang L, Walia R, et al. Controlled Hypothermic Storage and Time‐Shifting in Lung Transplantation: A Single‐Center Study. Clinical Transplantation. 2026;40(11). doi:10.1111/ctr.70684
BibTeX
@article{Keogan2026,
author = {Keogan, Andrew and Lin, Theodore and Shacker, Mark and Chang, Lucia and Wang, Lucas and Walia, Rajat and Bremner, Ross M and Huang, Jasmine and Zwintscher, Nathan and Smith, Michael A and Schaheen, Lara W},
title = {Controlled Hypothermic Storage and Time‐Shifting in Lung Transplantation: A Single‐Center Study},
journal = {Clinical Transplantation},
year = {2026},
volume = {40},
number = {11},
doi = {10.1111/ctr.70684}
}
EUVIMED